Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Swedish to advance personalized medicine program

The Swedish Cancer Institute (SCI) will advance its Personalized Medicine Program with the adoption of Syapse Precision Medicine Platform. 

Thumbnail

PCORI offers $120M for research funding

The Patient-Centered Outcomes Research Institute will dole out $120 million to fund 34 patient-centered clinical comparative and clinical effectiveness research studies on a range of conditions and patient populations.

Thumbnail

Tips for successful population health management from Mayo Clinic

CHICAGO—A good business plan is a better route to successful population health management than new IT, said Claudia Blackburn, PMP, MBA, manager and consultant with Aspen Advisors, speaking at the Clinical & Business Intelligence Symposium during the 2015 HIMSS Annual Conference & Exhibition.

Thumbnail

Submit your great idea for the Joy of Medicine challenge

An online competition aims to elicit new ideas on how to ease the burden of paperwork and other business-related activities that physicians say are hampering their ability to develop meaningful relationships with patients. 

Mass. provider opens innovation center

Atrius Health is the latest health system to open an innovation center.  

ZeOmega Completes 2015 Review of its Evidence-based Clinical Content for Patient Centered Care Management

PLANO, Texas – April 21, 2015 – ZeOmega Inc., a market leader in population health and care coordination solutions, today released its annual clinical content update which enables its clients to access the latest best practices in evidence-based medicine and care management.

Record quarter for VC funding in healthcare

U.S. medical startups raised a record $3.9 billion in venture capital in the first quarter of 2015 due to growing interest in biotechnology, digital health and healthcare services, according to the Dow Jones VentureSource 1Q'15 U.S. Venture Capital Report. 

Thumbnail

Few taking advantage of quality ratings, price comparisons

Despite the focus on patient engagement, price transparency and provider quality ratings, few individuals are using quality and pricing data on physicians and hospitals to make their healthcare choices, according to a Kaiser Family Foundation poll.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.